Apr 02, 2025
Immunovia publishes the Annual Report for 2024
Apr 01, 2025
The exercise period for warrants series TO 3 begins today
Mar 24, 2025
Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test
Mar 21, 2025
Immunovia to host a webcast to share more data from the successful VERIFI clinical validation study
Mar 19, 2025
Immunovia announces another successful clinical validation of its next-generation pancreatic cancer test
Mar 03, 2025
Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference
Feb 21, 2025
Immunovia initiates search for a new CFO to support commercialization in the USA
Feb 21, 2025
Invitation to Immunovia's Q4 presentation
Jan 08, 2025
Immunovia AB (Publ) presents Nomination Committee
Dec 28, 2024
Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme
Dec 20, 2024
Immunovia discovery study published in top protein research journal
Dec 19, 2024
End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding
Dec 18, 2024
Immunovia CEO and board members announce intention to fully exercise their TO2 warrants
Dec 16, 2024
Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test
Dec 11, 2024
Immunovia announces financial calendar for financial year 2025/2026
Dec 09, 2024
Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer
Oct 07, 2024
Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
Oct 02, 2024
Immunovia completes analytical validation of its next-generation pancreatic cancer test
Sep 16, 2024
Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
Aug 05, 2024
Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health